<!--The Official Report of Parliamentary Debates (Hansard) of the Legislative Council and the House of Assembly of the Parliament of South Australia are covered by parliamentary privilege. Republication by others is not afforded the same protection and may result in exposure to legal liability if the material is defamatory. You may copy and make use of excerpts of proceedings where (1) you attribute the Parliament as the source, (2) you assume the risk of liability if the manner of your use is defamatory, (3) you do not use the material for the purpose of advertising, satire or ridicule, or to misrepresent members of Parliament, and (4) your use of the extracts is fair, accurate and not misleading. Copyright in the Official Report of Parliamentary Debates is held by the Attorney-General of South Australia.-->
<hansard id="" tocId="" xml:lang="EN-AU" schemaVersion="1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xml="http://www.w3.org/XML/1998/namespace" xmlns:xsi="http://www.w3.org/2007/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:noNamespaceSchemaLocation="hansard_1_0.xsd">
  <name>Legislative Council</name>
  <date date="2020-05-14" />
  <sessionName>Fifty-Fourth Parliament, Second Session (54-2)</sessionName>
  <parliamentNum>54</parliamentNum>
  <sessionNum>2</sessionNum>
  <parliamentName>Parliament of South Australia</parliamentName>
  <house>Legislative Council</house>
  <venue></venue>
  <reviewStage>published</reviewStage>
  <startPage num="763" />
  <endPage num="859" />
  <dateModified time="2022-08-06T14:30:00+00:00" />
  <proceeding continued="true">
    <name>Question Time</name>
    <subject>
      <name>Influenza Vaccinations</name>
      <text id="20200514d0e5dc904a574ed190000302">
        <heading>Influenza Vaccinations</heading>
      </text>
      <talker role="member" id="5412" kind="question">
        <name>The Hon. C.M. SCRIVEN</name>
        <house>Legislative Council</house>
        <questions>
          <question date="2020-05-14">
            <name>Influenza Vaccinations</name>
          </question>
        </questions>
        <startTime time="2020-05-14T14:40:40" />
        <text id="20200514d0e5dc904a574ed190000303">
          <timeStamp time="2020-05-14T14:40:40" />
          <by role="member" id="5412">The Hon. C.M. SCRIVEN (14:40):</by>  A further supplementary question: will the minister explain to the chamber why he will not allow redistribution between clinics and why, instead, patients have to go chasing around to different locations in order to access this vaccine?</text>
      </talker>
      <talker role="member" id="3164" kind="answer">
        <name>The Hon. S.G. WADE</name>
        <house>Legislative Council</house>
        <portfolios>
          <portfolio id="">
            <name>Minister for Health and Wellbeing</name>
          </portfolio>
        </portfolios>
        <questions>
          <question date="2020-05-14">
            <name>Influenza Vaccinations</name>
          </question>
        </questions>
        <startTime time="2020-05-14T14:41:00" />
        <text id="20200514d0e5dc904a574ed190000304">
          <timeStamp time="2020-05-14T14:41:00" />
          <by role="member" id="3164">The Hon. S.G. WADE (Minister for Health and Wellbeing) (14:41):</by>  The opposition is showing yet again its ignorance of the way these things work. Influenza vaccines are very sensitive vaccines; you need to maintain the cold chain. There is significant risk in moving vaccines from facility to facility without the appropriate transport and so we would not do it. Certainly, redistribution of vaccines is an option that was mentioned earlier when there were issues raised in relation to supply and demand, but the fact that the audit is demonstrating that there is supply out there, it's a matter of making sure that, if you like, the demand meets the supply. We believe that's a much more appropriate response than risking damage to the vaccine which would actually make the client's visit futile.</text>
      </talker>
    </subject>
  </proceeding>
</hansard>